scorecard

You Searched For "glenmark pharmaceuticals" and got 20 results


Sort By:


Business Insider Latest Story Image
5 mins read

Glenmark Life Sciences IPO is nearly as big as its debt but the funds will go into expanding its plants

Glenmark Pharmaceuticals’ subsidiary Glenmark Life Sciences is all prepped up to launch its ₹1,060 …

Business Insider Latest Story Image
1 min read

Glenmark Pharma partners with SaNOtize for Nitric Oxide Nasal Spray for COVID-19 treatment

According to Glenmark, NONS will be sold in India and in Asian markets including Singapore, Mala…

Business Insider Latest Story Image
2 mins read

Glenmark shares hit upper circuit twice as its COVID-19 drug enters phase-3 clinical trial

The shares of Glenmark Pharmaceuticals climbed over 32% hitting the upper circuit set by the stock …

Business Insider Latest Story Image
1 min read

Glenmark launches first oral coronavirus drug in India called FabiFlu

FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the co…

PTI   


Business Insider Latest Story Image
2 mins read

Top stocks to watch — Vedanta, Wipro, RITES, Mazagon Dock, UTI AMC, Glenmark Pharma, and others

Amidst positive cues from the Asian markets, the Indian stock market is likely to open in green. Th…

Business Insider Latest Story Image
1 min read

Glenmark gets USFDA's final nod for Deferasirox tablets

New Delhi, Jan 7 () Glenmark Pharmaceuticals on Tuesday said it has got final approval from the US …

PTI   


Business Insider Latest Story Image
3 mins read

Glenmark launches COVID-19 drug at Rs 103 per tablet

When asked if the company is looking for tie-ups with hospitals for supply of the drug, it said: "O…

PTI   


Business Insider Latest Story Image
1 min read

Glenmark gets DCGI nod for favipiravir for treatment of COVID-19 patients '

"This approval has been granted based on evaluation of data and in consultation with the Subject Ex…

PTI   


Business Insider Latest Story Image
1 min read

Shares of Glenmark Pharmaceuticals struck a fresh high

Glenmark Pharmaceuticals, a front line drugs major, struck a fresh high on Wednesday after getting …

Business Insider Latest Story Image
1 min read

Glenmark board to consider fund raising options on Feb 14

The Mumbai-based firm plans to raise funds either through issuance of bonds or debentures, non-con…

PTI   


Business Insider Latest Story Image
1 min read

Glenmark gets approval from Australian regulator to commercialise Ryaltris

New Delhi, Dec 20 () Drug maker Glenmark Pharmaceuticals on Friday said that it has received approv…

PTI   


Business Insider Latest Story Image
1 min read

Glenmark Pharmaceuticals seeks shareholders' approval to raise funds for its expansion plans

In order to capitalise on various opportunities for further growth of the business, the company i…

Business Insider Latest Story Image
1 min read

Shares of Glenmark Pharmaceuticals and Indiabulls Housing Finance Ltd. recovered sharply

​Shares of Glenmark Pharmaceuticals Ltd. and Indiabulls Housing Finance Ltd. recovered sharply from…

Business Insider Latest Story Image
1 min read

Glenmark Pharma shares soar 27 pc after COVID-19 drug launch

The drug firm on Saturday said it has launched antiviral drug FabiFlu for the treatment of patients…

PTI   


Business Insider Latest Story Image
1 min read

Shares of Glenmark Pharma hit fresh record highs

Shares of Glenmark Pharma, a frontline drugs major, hit fresh record highs on news the stock has be…

Business Insider Latest Story Image
2 mins read

Glenmark inks licensing pact with Hikma for commercialisation of nasal spray Ryaltris in US

"We are happy to partner with Hikma in the US as Ryaltris is a perfect strategic fit in their near-…

PTI   


Business Insider Latest Story Image
2 mins read

Glenmark cuts price of COVID-19 drug by 27 pc to Rs 75 per tablet

When asked about the company's manufacturing capacity of the drug, Glenmark had earlier said: "Cons…

PTI   


Business Insider Latest Story Image
2 mins read

Glenmark Pharma cuts price of COVID-19 drug by 27 pc to Rs 75/tablet

"Our internal research shows us that we launched FabiFlu in India at the lowest market cost as com…

PTI   


Business Insider Latest Story Image
1 min read

Glenmark gets tentative nod from USFDA for generic type-2 diabetes tablets

Citing IQVIA sales data for the 12 month period ending January 2020, the company said Farxiga tabl…

PTI   


Business Insider Latest Story Image
1 min read

Mankind Pharma inks licensing pact with Glenmark to co-market diabetes drug

New Delhi, Dec 23 () Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glen…

PTI